Metildigoxin Other names: Medigoxin beta-Methyldigoxin Methyldigoxin

Chemical formula: C₄₂H₆₆O₁₄  Molecular mass: 794.976 g/mol 

Active ingredient description

Metildigoxin, a methyl derivative of digoxin, is a cardiac glycoside a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
C01AA08 Metildigoxin C Cardiovascular system → C01 Cardiac therapy → C01A Cardiac glycosides → C01AA Digitalis glycosides
Discover more medicines within C01AA08

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 30685-43-9
DrugBank Drug: DB13401
RxNorm Ingredient: 6686
SNOMED-CT Concept: 418574005
Metildigoxin (substance)
UNII Identifier: I7GG1YUC5V
METILDIGOXIN

Medicines

Metildigoxin is an active ingredient of these brands:

Austria (AT)

  • LANITOP as Metildigoxin semiacetone

Croatia (HR)

  • LANITOP as Metildigoxin semiacetone

Germany (DE)

  • LANITOP as Metildigoxin semiacetone

Japan (JP)

Poland (PL)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈